These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26296911)

  • 1. 3-Benzamides and 3,4,5-trimethoxyphenyl amines as calcium channel blockers.
    Kang B; Oh JA; Lee JY; Rhim H; Yune TY; Park Choo HY
    Bioorg Med Chem; 2015 Sep; 23(18):6166-72. PubMed ID: 26296911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
    Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
    Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
    Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels.
    Ogiyama T; Inoue M; Honda S; Yamada H; Watanabe T; Gotoh T; Kiso T; Koakutsu A; Kakimoto S; Shishikura J
    Bioorg Med Chem; 2014 Dec; 22(24):6899-907. PubMed ID: 25456079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain.
    Yang HK; Son WS; Lim KS; Kim GH; Lim EJ; Gadhe CG; Lee JY; Jeong KS; Lim SM; Pae AN
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1460-1471. PubMed ID: 30231778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca
    Wall MJ; Subasinghe NL; Winters MP; Lubin ML; Finley MFA; Qin N; Brandt MR; Neeper MP; Schneider CR; Colburn RW; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3780-3783. PubMed ID: 30337231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icilin reduces voltage-gated calcium channel currents in naïve and injured DRG neurons in the rat spinal nerve ligation model.
    Hagenacker T; Lampe M; Schäfers M
    Brain Res; 2014 Apr; 1557():171-9. PubMed ID: 24560602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers.
    Du Nguyen H; Okada T; Kitamura S; Yamaoka S; Horaguchi Y; Kasanami Y; Sekiguchi F; Tsubota M; Yoshida S; Nishikawa H; Kawabata A; Toyooka N
    Bioorg Med Chem; 2018 Aug; 26(15):4410-4427. PubMed ID: 30031654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huwentoxin-XVI, an analgesic, highly reversible mammalian N-type calcium channel antagonist from Chinese tarantula Ornithoctonus huwena.
    Deng M; Luo X; Xiao Y; Sun Z; Jiang L; Liu Z; Zeng X; Chen H; Tang J; Zeng W; Songping Liang
    Neuropharmacology; 2014 Apr; 79():657-67. PubMed ID: 24467846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice.
    Sekiguchi F; Fujita T; Deguchi T; Yamaoka S; Tomochika K; Tsubota M; Ono S; Horaguchi Y; Ichii M; Ichikawa M; Ueno Y; Koike N; Tanino T; Nguyen HD; Okada T; Nishikawa H; Yoshida S; Ohkubo T; Toyooka N; Murata K; Matsuda H; Kawabata A
    Neuropharmacology; 2018 Aug; 138():232-244. PubMed ID: 29913186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and T-type calcium channel-blocking effects of aryl(1,5-disubstituted-pyrazol-3-yl)methyl sulfonamides for neuropathic pain treatment.
    Kim JH; Keum G; Chung H; Nam G
    Eur J Med Chem; 2016 Nov; 123():665-672. PubMed ID: 27517811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-allodynic effect of 2-(aminomethyl)adamantane-1-carboxylic acid in a rat model of neuropathic pain: a mechanism dependent on CaV2.2 channel inhibition.
    Zoidis G; Sandoval A; Pineda-Farias JB; Granados-Soto V; Felix R
    Bioorg Med Chem; 2014 Mar; 22(6):1797-803. PubMed ID: 24582401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
    Wen XJ; Xu SY; Chen ZX; Yang CX; Liang H; Li H
    Pharmacology; 2010; 85(5):295-300. PubMed ID: 20453553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain.
    Matthews EA; Bee LA; Stephens GJ; Dickenson AH
    Eur J Neurosci; 2007 Jun; 25(12):3561-9. PubMed ID: 17610575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 1-(isoxazol-5-ylmethylaminoethyl)-4-phenyl tetrahydropyridine and piperidine derivatives as potent T-type calcium channel blockers with antinociceptive effect in a neuropathic pain model.
    Lee JH; Seo SH; Lim EJ; Cho NC; Nam G; Kang SB; Pae AN; Jeong N; Keum G
    Eur J Med Chem; 2014 Mar; 74():246-57. PubMed ID: 24480356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 6-pyrazoylamido-3N-substituted azabicyclo[3,1,0]hexane derivatives as T-type calcium channel inhibitors for treatment of neuropathic pain.
    Kim JH; Nam G
    Bioorg Med Chem; 2016 Nov; 24(21):5028-5035. PubMed ID: 27591007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model.
    Son WS; Jeong KS; Lim SM; Pae AN
    Bioorg Med Chem Lett; 2019 May; 29(10):1168-1172. PubMed ID: 30928197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
    Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
    Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic pain.
    Beebe X; Yeung CM; Darczak D; Shekhar S; Vortherms TA; Miller L; Milicic I; Swensen AM; Zhu CZ; Banfor P; Wetter JM; Marsh KC; Jarvis MF; Scott VE; Schrimpf MR; Lee CH
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4857-61. PubMed ID: 23876987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury.
    Yue J; Liu L; Liu Z; Shu B; Zhang Y
    Spine (Phila Pa 1976); 2013 Mar; 38(6):463-70. PubMed ID: 22972512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.